Research News

NIH – Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or…

American Diabetes Association

Purpose: ADA is soliciting research to elicit sustained behavioral change at the individual and community level with interventions tailored to different racial and socioeconomic groups across the life span. Importantly,…

NICHD – NICHD Neonatal Research Network (NRN): Clinical Centers (UG1 Clinical Trial Optional)

Purpose: The purpose of the Neonatal Research Network (NRN) is to improve healthcare and outcomes for newborns. This includes finding ways to improve the chances for survival without neurodevelopmental impairment…

NIH – MedTech

Purpose: This funding opportunity is focused on supporting translational activities and clinical studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular…

Cystic Fibrosis Foundation

Purpose: Small molecule CFTR modulators that directly target the mutant protein are powerful therapies that will likely benefit 90% of people with CF in the near future. However, there is…

Foundation for Sarcoidosis Research (FSR)

Purpose: The Foundation for Sarcoidosis Research (FSR) Cardiac Sarcoidosis Grant aims to support research conducted in cardiac sarcoidosis. Background: The project, which can be supported either singularly by FSR or…

NIH – HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)

Purpose: This funding opportunity announcement (FOA) is part of a suite of FOAs to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal of this…

NIH – Innovation Award: Minority Health and Health Equity (U01) Clinical Trials Optional

Purpose: The purpose of this funding opportunity announcement (FOA) is to fund innovative research that will strengthen and advance minority health and health equity research. Areas of interest include: Proposals…

NIH – Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)

Purpose: This Funding Opportunity Announcement (FOA) supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt,…

NIH – A Community Research Resource: Characterization of the Resident Ocular Microbiome. (U24 Clinical Trial Not Allowed)

Purpose: The overall purpose of this funding opportunity announcement (FOA) is to invite applicants from multidisciplinary research teams to develop a community-based resource of microbial data associated with the resident…

Pandemic Antiviral Discovery

PURPOSE AND RESEARCH FIELDS This RfP will support projects that seek to elucidate the molecular determinants of henipavirus replication, pathogenesis and transmission for the purpose of developing therapeutic discovery programs…

Ovarian Cancer Research Alliance – multiple opportunities

Collaborative Research Development Grant Launched in 2004, this grant provides funds for large ovarian cancer research projects that involve several investigators within one institution or collaborations between groups in multiple…

Case Western – Hair Follicle Inflammatory Disease Biology (HFIDB) Research Grant

Purpose: The Department of Dermatology at University Hospitals Cleveland Medical Center and Case Western Reserve University invites Early Career Investigators working at the level of Instructor through Associate Professor in…

NIH – Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 – Clinical Trials Optional)

Purpose: The purpose of this initiative is to support research that seeks to (1) understand the underlying mechanisms and (2) test interventions to address and mitigate the impact of health-related…

NIH – Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R21 – Clinical Trial Not Allowed)

Purpose: This Funding Opportunity Announcement (FOA) encourages exploratory and developmental research to better understand the role of social connectedness and/or loneliness in prevention, treatment and recovery from substance use disorders…

NIH – Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, Cocaine and/or Cannabinoid Exposures (U01 – Clinical Trial Not Allowed)

Purpose: The National Institute on Drug Abuse (NIDA) seeks applications that support generation of single cell RNA-sequencing data sets for at least one brain region relevant to persistent HIV infection…

Novo Nordisk and Gates Foundations

The Novo Nordisk Foundation, Open Philanthropy, and the Bill & Melinda Gates Foundation have launched the Pandemic Antiviral Discovery (PAD) initiative to catalyze discovery and early development of antiviral medicines…

NIH – CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect (P50) (Clinical Trial Optional)

Purpose: This Request for Applications (RFA) is being re-issued to continue to stimulate collaborative research on all forms of child abuse and neglect and to foster dissemination and outreach efforts…

NIH – BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs – eTeamBCP (U01 Clinical Trials Optional)

Purpose: This funding opportunity announcement (FOA) is designed to support teams of three or more (up to six) PDs/PIs that seek to cross boundaries of interdisciplinary collaboration to elucidate the…

NIH – Coordinating Center to Support Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (U24 Clinical Trial Not Allowed)

Purpose: The purpose of this FOA is to seek applications for a Coordinating Center (CC) for Community-Level Interventions for Firearm Violence Prevention (CLIF-VP) Research Network. Members of the CLIF-VP Research…

NIH – Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed)

Purpose: This Funding Opportunity Announcement (FOA) invites applications to participate in the Immune Drivers of Autoimmune Disease (IDAD) cooperative research program, which will focus on defining the immunologic states and…

NIH – Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)

Purpose: The National Institutes of Health (NIH) is issuing this Funding Opportunity Announcement (FOA) in response to the declared public health emergency issued by the Secretary, HHS, for the Novel…

NIH – HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes & Cells (U19 Clinical Trial Not Allowed)

Purpose: The purpose of this funding opportunity announcement is to support research that uses human tissue or cells to generate comprehensive datasets for the discovery and characterization of functional genetic…

NIH – BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)

Purpose: The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative Funding Opportunity Announcement is to encourage applications that will develop and validate novel tools to facilitate the…

NIH – Emergency Award HEAL Initiative: Optimizing Existing Evidence-Based Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional)

Purpose: NIMH is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS. See “Determination that a Public Health Emergency Exists Nationwide as the…